Search Results 11-20 of 17396 for Bronchiectasis
Clinical Trials · A Study to Assess the Effectiveness and Safety of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis · More about research at ...
... bronchiectasis with eosinophilic inflammation (NCFB+EI). All patients who complete the 52-week double-blind treatment period on investigational product (IP) ...
At Mayo Clinic, Ben received a correct diagnosis for his condition: a chronic pulmonary disease called bronchiectasis. Moreover, Ben and his family were assured ...
The lining of the tubes that carry air to and from your lungs is inflamed. Signs and symptoms include cough, mucus, fatigue and chest discomfort.
Effect of training the breathing muscles on the ability to exercise in people with non-cystic fibrosis bronchiectasis · Overview · Participation eligibility.
Non-Cystic Fibrosis Bronchiectasis. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments ...
The purpose of this study is to evaluate if the time to first pulmonary exacerbation of bronchiectasis or its frequency can be prolonged by inhalation of ...
Description. Brensocatib is used to treat non-cystic fibrosis bronchiectasis (NCFB). This medicine is available only with your doctor's prescription. This ...
Bronchiectasis, atelectasis, and cavitary or cystic lung diseases. In: Goldman-Cecil Medicine. 27th ed. Elsevier; 2024. https://www.clinicalkey.com ...
A Study to Assess the Effectiveness, Safety, and Tolerability of Brensocatib in Participants with Non-Cystic Fibrosis Bronchiectasis (ASPEN) · Overview.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.